MiNK Therapeutics Announces Virtual Annual Shareholders Meeting
June 10, 2025 13:33 ET Â | Source: MiNK Therapeutics NEW YORK, June…
RESTEM to Present Phase 2/3 IIMPACT Trial Design in Idiopathic Inflammatory Myopathy at EULAR 2025 Congress
June 06, 2025 16:07 ET Â | Source: Restem MIAMI, June 06, 2025…